Abstract
Stefan Flasche and colleagues consider whether the number of PCV doses in the infant schedule could be reduced without compromising its public health benefit in high-income settings.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Developed Countries*
-
Health Policy
-
Heptavalent Pneumococcal Conjugate Vaccine / administration & dosage*
-
Heptavalent Pneumococcal Conjugate Vaccine / immunology*
-
Humans
-
Immunity, Herd*
-
Immunization Schedule
-
Pneumococcal Infections / immunology*
-
Pneumococcal Infections / prevention & control*
Substances
-
Heptavalent Pneumococcal Conjugate Vaccine